- Cannabis producer Aurora Cannabis beat on the top line.
- The company said its margins were lower as production costs jumped and prices fell.
- It reiterated its guidance of achieving positive EBITDA beginning in the second quarter of calendar 2019 (its fiscal Q4).
- Watch Aurora Cannabis trade live.
Cannabis producer Aurora Cannabis dropped 2.51% to $US6.99 per share early Tuesday after reporting lower second-quarter margins as production costs jumped and prices fell.
The company on Monday said it generated 54.2 million Canadian dollars ($US40.9 million) in sales, which represented a 363% rise from the prior year. Analysts surveyed by Bloomberg were expected 52.6 million Canadian dollars ($US39.7 million).
But the company said its gross margin fell to 54% from 70% on a quarterly basis, primarily due to a lower average selling price per gram of cannabis, increased packaging costs, and the impact of excise taxes on medical cannabis revenues. As a result, the company lost 238 million Canadian dollars ($US180 million) in the quarter.
“Our brands continue to resonate extremely well in the consumer market, our patient numbers continue to increase steadily, and we have maintained our market leadership in Germany and other key international markets,” said CEO Terry Booth in a press release. “We are experiencing exceptional demand for our Canadian medical and consumer products, as well as sustained strong demand internationally.”
Looking ahead, the company reiterated its guidance of achieving positive EBITDA beginning in the second quarter of calendar 2019 (its fiscal Q4).
Aurora went public on the New York Stock Exchange in October in the wake of the official legalization of recreational marijuana in Canada. It has since stepped up expanding its reach in the US market, where the regulatory environment has become more favourable for marijuana producers.
On January 14, less than one month after the passage of the Farm Bill, which legalised hemp, a source of the popular ingredient cannabidiol, Aurora told Business Insider it plans to produce hemp-derived CBD for the US market in the next few months.
The stock is very popular among millennials. Since the week through February 1, Aurora has outranked all other stocks including Apple on Robinhood, a free-trading app popular among younger investors, in terms of the number of shareholders.
Aurora is up 45% so far this year.
- Millennials keep pouring money into marijuana stocks
- These execs are leaving behind careers at companies like Coke and Victoria’s Secret to tap into the $US194 billion marijuana industry
- Marijuana could be the biggest growth opportunity for struggling beverage-makers as millennials ditch beer for pot
- Aurora Cannabis is gearing up to break into the $US1.6 billion CBD industry in the US